HOME > PUBLICATIONS > Clinical Research
| File | |
|---|---|
| Date | 2013-11-01 |
| Journal | Kim JW, Kim JH, Im SA, Lee KH, Kim JS, Kim TY, Han SW, Jeon YK, Oh DY, Kim TY, Park IA., Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy. Cancer Chemother Pharmacol. 2013 Nov;72(5):1023-9. |
| Visits | 473 |
